Parkinson’s Disease: How Pharmacists Can Make a Difference Marsha K. Millonig, MBA, RPh President & CEO Catalyst Enterprises, LCC.
Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT) Trial Mohsen Sharifi, Curt Bay, Laura Skrocki, Farnoosh Rahimi, Mahshid Mehdipour A.T.Still.
LIVER - Normal histology - Cirrhosis
Non Hodgkin’s lymphoma
T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, ) In all T1 patients failing intravesical therapy muscle-invasive.
Pankreatitis Kronik
Testing123
indication
Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008
Epidemiology Prevalence Increase with age 25% of the white males vs. 17% in white females 44% of black males vs. 37% in black femals Indifference between.
Interpreting blood tests and the ECG: practical risk assessment Dr T S Dhanjal PhD MRCP Cardiovascular courses 29 th October 2008.
1 Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008 Workshop Minimizing risk by optimizing clinical trial design and performance.
